select a format

Single User License
USD 250 INR 16255
Site License
USD 500 INR 32510
Corporate User License
USD 750 INR 48765

Alternatively

Request a quote
Request a Customized research
Request for Sample Report

NEWSLETTER BY CATEGORY




Recent Viewed Reports


Why Ken Reasearch?


Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"


WuXi NextCODE Genomics-Pharmaceuticals & Healthcare-Deals and Alliances Profile

WuXi NextCODE Genomics-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH287805D
  • |
  • Pages: 23
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

WuXi NextCODE Genomics (WuXi NextCODE), formerly NextCODE Health is a subsidiary of WuXi PharmaTech (Cayman), Inc., medical device company that offers clinical diagnostics services. The company delivers genomics platform to help physicians obtain actionable clinical insights. Its products include NextCODExchange that enables users to collaborate and validate findings in real time. WuXi NextCODE harnesses its GOR informatics system to standardize, manage and query massive sequence data besides computational efficiency. The company's services include genome analysis and interpretation, big data management and storage, custom integration and next generation sequencing. Its platform comprises NextCODE calibrated pipeline and algorithms; NextCODE clinical sequence analyzer; NextCODE knowledge base; and NextCODE clinical-grade sequencing. The company operates through its offices located in Shanghai; Cambridge; and Reykjavik. WuXi NextCODE is headquartered in Cambridge, Massachusetts, the US.

WuXi NextCODE Genomics-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

WuXi NextCODE Genomics, Medical Devices Deals, 2011 to YTD 2017 9

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

NextCode Health Raises USD15 Million in Series A Financing 11

Partnerships 11

AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 11

Genomics England Enters into Contract Agreement with WuXi NextCODE 12

SA1KCGP, WuXi NextCODE and START Enter into Partnership 13

WuXi NextCODE Genomics Enters into Agreement with Sidra Medical and Research Center 14

NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 15

Acquisition 16

WuXi PharmaTech Acquires NextCODE Health for USD65 Million 16

WuXi NextCODE Genomics-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Corporate Communications 20

Feb 28, 2017: WuXi NextCODE Appoints Hannes Smarason as CEO, John Long as CFO, and Alex Fowkes as COO 20

Legal and Regulatory 21

Feb 23, 2016: WuXi NextCODE Becomes the First and Only CAP, CLIA, and California Accredited Sequencing Laboratory in China 21

Government and Public Interest 22

May 15, 2017: WuXi NextCODE AI Points to New Therapeutic Approaches to Cardiovascular Disease and Cancer in Yale Nature study 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23

List of Figures

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

WuXi NextCODE Genomics, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Key Facts 1

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

WuXi NextCODE Genomics, Deals By Therapy Area, 2011 to YTD 2017 8

WuXi NextCODE Genomics, Medical Devices Deals, 2011 to YTD 2017 9

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

NextCode Health Raises USD15 Million in Series A Financing 11

AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 11

Genomics England Enters into Contract Agreement with WuXi NextCODE 12

SA1KCGP, WuXi NextCODE and START Enter into Partnership 13

WuXi NextCODE Genomics Enters into Agreement with Sidra Medical and Research Center 14

NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 15

WuXi PharmaTech Acquires NextCODE Health for USD65 Million 16

WuXi NextCODE Genomics, Key Competitors 17

WuXi NextCODE Genomics, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

WuXi NextCODE Genomics, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com